Max Rady College of Medicine
Concept: Methamphetamine Use in Manitoba
Concept Description
Last Updated: 2025-04-07
Introduction
-
This concept describes the definition of methamphetamine, data sources used at MCHP and various methods used in the MCHP research to identify individuals with administrative record that documented their methamphetamine use.
Definition
-
Methamphetamine is a central nervous stimulant known by several street names including meth, crystal meth and rock. Methamphetamine can be injected, inhaled, snorted or taken orally. Methamphetamine use results in wakefulness, vigor, euphoria and reduced appetite, and contributes to severe physical health complications that may include lethal hyperthermia, myocardial infarction (heart attack), stroke, seizure and death.
Data Sources
-
The data sources used in this MCHP research to identify individuals with methamphetamine use included:
Methods
-
The following methods were used to identify Methamphetamine use in different databases:
1. Hospital Discharge Abstract Database
ICD-10 and ICD-9 codes for amphetamine-related disorders; harms related to amphetamine use (e.g., poisoning from amphetamine). The codes used include:
ICD-10-CA ICD-9-CM Issue F15.0 292.89 Amphetamine intoxication F15.1 305.7-305.73,305.9-305.93 Methamphetamine use F15.2 304.4-304.43,305.7 Methamphetamine addiction F15.3 292 Amphetamine withdrawal F15.5 292.11,292.12 Amphetamine and psychostimulant induced psychotic disorder with delusions F15.8 292.84,292.85,292.89 Amphetamine induced anxiety disorder F15.9 292.9 Amphetamine related mental disorder T43.6 969.7-969.73,969.79,970.89,970.9 Overdose of psychostimulant T50.9 970.9,977,977.9 Drug overdose T65.9 No code Poisoning Y49.7 E939.7 Adverse effect of amphetamine Y63.9 E873.8 Underdose of amphetamine Z86.48 305.73 History of methamphetamine abuse Z91.8 V15.6 History of poisoning
To see the complete list of codes refer to Appendix Table1.12.Medical Claim Databse
5 digits of several ICD-9 codes were used to identify individuals who used methamphetamine in the Medical Claims Database. They included:
- 304.4X: Amphetamine and other psychostimulant dependence
- 305.7X: Amphetamine abuse
- 969.72: Poisoning by amphetamines
3.Emergency Department Information System (EDIS)
Keyword searches in triage notes to identify people presenting with an indication of having used methamphetamine. These data were limited to Winnipeg.
To see the complete list of search terms refer to Appendix Table 1.24.Winnipeg Fire Paramedic Service (WFPS) Database
Indications searches of Methamphetamine use in the database of WFPS electronic patient care reports were used. This database consists of core and subsidiary datasets corresponding to parts of the patient record, including patient assessments, vital signs, interventions and a free text narrative. In consultation with the principal investigator, two research team members did a preliminary review of approximately 15% of comments to develop inclusion criteria. All remaining records were reviewed by one team member with assistance from WFPS analyst. A portion (10%) of these records was randomly selected to be independently coded by both reviewers; decisions on these records showed very good agreement: kappa=0.865(95% CI 0.814-0.916),p<0.0005)
5.Diagnostic Services Manitoba (DSM)
Diagnostic tests where methamphetamine use identified. Two drug tests were considered.
- TEST_CODE=1663(methamphetamine)
- TEST_CODE=1605(drug screen)
NOTE: To construct the cohort, all the records documenting methamphetamine use from 5 databases were combined. If an individual had records from the multiple sources indicating methamphetamine use on the same date, their records were sorted into the following chronological order:(1)WFPS, (2)EDIS, (3)Hospital, (4)Medical Claims and (5)DSM. This was done to identify a person's "first point of contact" for methamphetamine use documentation based on the expected flow through the health system. Figure 2.1 in the deliverable presents a flow chart illustrating the process used to construct the cohort.
To see the details of these methods refer to Methods in the deliverable.
Exclusions
-
The following exclusions were applied to the cohort:
-
Anyone lacking a valid PHIN and anyone not covered by Manitoba Health at the date of their methamphetamine use were excluded because without the PHIN or healthcare coverage, records across databases cannot be linked.
-
Individuals diagnosed with ADHD and had been dispensed prescription medication for amphetamine use were also excluded. ADHD was defined using a previously established algorithm in the deliverable
Mental Illness Among Adult Manitobans
by
Chartier et al. (2018)
. The full case definition is provided in
Appendix Table 1.1
These individuals were excluded because their health care contact could have been due to an adverse reaction to the ADHD medications and not the methamphetamine use.
- People younger than 10 years old from the health service were also excluded because there were so few children in the cohort under the age of 10 that their results would be unstable and would need to be suppressed to protect their identity.
Cautions
-
Absence of emergency department and paramedic service data from regions beyond Winnipeg, restricts the ability to offer a comprehensive provincial perspective.
Related concepts
- Mental Disorder / Mental Health Disorder / Mental Health Illness Classification
- Substance Use Disorders / Substance Abuse - Measuring Prevalence
Related terms
- Any Mental Disorder / Any Mental Health Disorder / Any Mental Illness
- Diagnostic Services Manitoba (DSM)
- Emergency Department Information System (EDIS) Data
- Hospital Discharge Abstracts Database
- Medical Claims
- Mental Health Disorder / Mental Disorder
- Substance Abuse Prevalence
- Substance Use Disorders / Substance Abuse
- Winnipeg Fire Paramedic Service (WFPS) Data
References
- Nickel NC, Chartier M, McDonald N, Sarkar J, Dragan R, McCulloch S, Burchill C, Reimer J, Green C, Jones J, Sanguins J. Methamphetamine Use in Manitoba: A Linked Administrative Data Study. Winnipeg, MB: Manitoba Centre for Health Policy, 2020. [Report] [Summary] [Additional Materials] (View)
Keywords
- Health Measures
- Substance Abuse,Intravenous
Request information in an accessible format
If you require access to our resources in a different format, please contact us:
- by phone at 204-789-3819
- by email at info@cpe.umanitoba.ca
We strive to provide accommodations upon request in a reasonable timeframe.
Contact us
Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada